Dulac Edward J Iii

EDGAR CIK 0001821530

Fate Therapeutics Inc - FATE

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
4
($77,937)
-16,506 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/04/2024
10b5-1
03/05/2024
Sell
-2,447 @ $7.77
 ($19,013) 101,479 (-2.35%) Direct
01/29/2024
10b5-1
01/30/2024
Sell
-1,849 @ $5.00
 ($9,245) 103,926 (-1.75%) Direct
01/09/2024
01/10/2024
Sell
-7,028 @ $4.37
 ($30,712) 105,775 (-6.23%) Direct
01/02/2024
10b5-1
01/03/2024
Sell
-5,182 @ $3.66
 ($18,966) 112,803 (-4.39%) Direct